Community Financial Services Group’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$102K Sell
663
-1,634
-71% -$245K 0.01% 169
2026
Q1
$356K Sell
2,297
-1,228
-35% -$188K 0.06% 86
2025
Q4
$486K Sell
3,525
-371
-10% -$48.6K 0.09% 74
2025
Q3
$500K Hold
3,896
0.09% 75
2025
Q2
$471K Sell
3,896
-271
-7% -$30.5K 0.09% 71
2025
Q1
$465K Sell
4,167
-49,785
-92% -$5.3M 0.1% 73
2024
Q4
$5.25M Sell
53,952
-236
-0.4% -$25.2K 1.04% 34
2024
Q3
$6.23M Buy
54,188
+1,236
+2% +$140K 1.28% 29
2024
Q2
$5.64M Buy
52,952
+3,292
+7% +$330K 1.21% 27
2024
Q1
$4.8M Buy
+49,660
New +$5.09M 1.09% 27
2023
Q3
$856K Buy
+8,403
New +$853K 0.22% 63
2015
Q2
Sell
-15
Closed -$1K 321
2015
Q1
$1K Buy
+15
New +$1.33K ﹤0.01% 319

Other funds holding NVS

Community Financial Services Group's NVS Position: Q2 2026 in Review

Community Financial Services Group reduced its Novartis (NVS) stake by 71% in Q2 2026, selling an estimated $245K and leaving 663 shares worth $102K. The position accounts for 0.01% of the portfolio, ranked #169.

Community Financial Services Group first reported a position in NVS in Q1 2015 and has held it in 12 quarters since. The position peaked at $6.23M in Q3 2024. 325 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Community Financial Services Group held 663 shares of Novartis worth $102K as of Q2 2026.
  • Community Financial Services Group sold 1,634 Novartis shares in Q2 2026, an estimated $245K.
  • Novartis made up 0.01% of Community Financial Services Group's portfolio in Q2 2026, its #169 holding.
  • Community Financial Services Group first reported a position in Novartis in Q1 2015 and has held it in 12 quarters since.
  • Community Financial Services Group's Novartis position peaked at $6.23M in Q3 2024.
  • 325 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Community Financial Services Group's 13F filing for Q2 2026, filed 9 Jul 2026.